Pharma groups lose £30bn of value on heartburn drug lawsuit worries - Financial Times
- Pharma groups lose £30bn of value on heartburn drug lawsuit worries Financial Times
- Pfizer Stock Slumps Amid Litigation Concerns Linked to Zantac Heartburn Drug TheStreet
- Pharmaceutical Stocks GSK, Sanofi, Haleon Lose Billions As Zantac Recall Trial Looms | Investor's Business Daily Investor's Business Daily
- Jim Cramer breaks down drug stocks amid concerns over Zantac litigation CNBC Television
- View Full Coverage on Google News